Coining a new term-Urovesicology: advancing towards a mechanistic understanding of bladder symptoms

When patients present with lower urinary tract symptoms (urgency, frequency, nocturia, slow stream, hesitancy, sense of incomplete emptying, post-void dribbling), urinary incontinence (stress and urge), urinary retention, dysuria, and/or bladder pain, the urologist would be the most appropriate specialist to evaluate and treat these patients. These symptoms will be collectively labeled as "urovesicologic" symptoms, the reason which will become apparent. Because these symptoms usually have no known cause, empiric (trial-and-error) treatments directed at ameliorating symptoms, but not at the underlying pathophysiology, are the usual recourse.

• Publication year

  2012

• Venue

  Translational Andrology and Urology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3978/j.issn.2223-4683.2011.12.02PMID 26816687PMCID 4713223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey.

  2012cited by this paper
• Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study.

  2012cited by this paper
• Stem Cell Therapy for Stress Urinary Incontinence: A Critical Review

  2012cited by this paper
• Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization.

  2011cited by this paper
• Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.

  2011cited by this paper
• PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

  2011cited by this paper
• Quantitative Proteomics Identifies a β-Catenin Network as an Element of the Signaling Response to Frizzled-8 Protein-Related Antiproliferative Factor*

  2011cited by this paper
• Safety and Effectiveness of an Internal Pelvic Myofascial Trigger Point Wand for Urologic Chronic Pelvic Pain Syndrome

  2011cited by this paper
• Continent women have better urethral neuromuscular function than those with stress incontinence

  2011cited by this paper
• Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment.

  2011cited by this paper
• Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.

  2010cited by this paper
• Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes.

  2010cited by this paper
• Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Pelvic Floor Spasm: Can We Diagnose and Treat?

  2010cited by this paper
• Genetics and the lower urinary tract

  2010cited by this paper
• Research ethics. Questions from China snag U.S. trial of nerve-rerouting procedure.

  2010cited by this paper
• Can urinary nerve growth factor be a biomarker for overactive bladder?

  2010influential reference
• Outcomes of lumbar to sacral nerve rerouting for spina bifida.

  2010cited by this paper
• Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study.

  2010cited by this paper
• Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.

  2010cited by this paper
• Is the urothelium intelligent?

  2010cited by this paper
• Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men

  2010cited by this paper
• Why do women have stress urinary incontinence?

  2010cited by this paper
• Tolterodine causes measurable restoration of urethral sensation in women with urge urinary incontinence

  2010cited by this paper
• Social stress in mice induces voiding dysfunction and bladder wall remodeling.

  2009cited by this paper
• Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment

  2009influential reference
• Stem cells and spinal cord regeneration.

  2009influential reference
• Social stress-induced bladder dysfunction: potential role of corticotropin-releasing factor.

  2009cited by this paper
• Weight loss to treat urinary incontinence in overweight and obese women.

  2009cited by this paper
• Observations relating to urinary sensation during detrusor overactivity

  2009cited by this paper
• Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.

  2009cited by this paper
• Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder

  2009cited by this paper
• Impact of overactive bladder on the brain: Central sequelae of a visceral pathology

  2008cited by this paper
• Bladder control, urgency, and urge incontinence: Evidence from functional brain imaging

  2008cited by this paper
• Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome.

  2008cited by this paper
• Summation model of pelvic pain in interstitial cystitis

  2008cited by this paper
• Role of urothelial nerve growth factor in human bladder function

  2007cited by this paper
• The function of suburothelial myofibroblasts in the bladder

  2007cited by this paper
• Prevalence of pelvic floor dysfunction in patients with interstitial cystitis.

  2007cited by this paper
• Organ cross talk modulates pelvic pain.

  2007cited by this paper
• Cerebral control of the bladder in normal and urge-incontinent women

  2007cited by this paper
• Urethral and bladder current perception thresholds: normative data in women.

  2007cited by this paper
• Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG)

  2007cited by this paper
• Tissue-engineered autologous bladders for patients needing cystoplasty.

  2006cited by this paper
• Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators

  2006cited by this paper
• Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.

  2005cited by this paper
• Percutaneous neuromodulation.

  2005cited by this paper
• Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III)

  2005cited by this paper
• Serum C‐reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III)

  2005cited by this paper
• Micturition and the soul

  2005cited by this paper
• An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide.

  2004influential reference
• Corticotropin releasing factor: a mediator of emotional influences on bladder function.

  2004cited by this paper
• The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence

  2003cited by this paper
• Duloxetine versus placebo in the treatment of stress urinary incontinence.

  2002cited by this paper
• TLR4‐dependent recognition of lipopolysaccharide by epithelial cells requires sCD14

  2002cited by this paper
• A comparison of multiple urine markers for interstitial cystitis.

  2002influential reference
• Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction

  2002cited by this paper
• Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety.

  2000cited by this paper
• Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

  1999cited by this paper
• SACRAL NERVE STIMULATION FOR TREATMENT OF REFRACTORY URINARY URGE INCONTINENCE

  1999cited by this paper
• Neurally mediated hyperactive voiding in spontaneously hypertensive rats.

  1998cited by this paper
• The female urethral syndrome: external sphincter spasm as etiology.

  1980cited by this paper

• Can preoperative urodynamic studies predict de novo stress urinary incontinence following advanced pelvic organ prolapse surgery?

  2025cites this paper
• Making sense of urodynamic studies for women with urinary incontinence and pelvic organ prolapse: a urogynecology perspective.

  2012cites this paper